Mesoblast (MESO) Divestments (2014 - 2023)
Mesoblast (MESO) posted Divestments of -$40000.0 for Q1 2023, down 17.65% sequentially from -$34000.0 in Q4 2022, and down 471.43% YoY from $10769.2 in Q1 2022.
Powered by 
Analysis
Mesoblast (MESO) Divestments (2014 - 2023) Analysis & Trends
Mesoblast has reported Divestments for 8 years, with the latest figure at -$40000.0 in Q1 2023.
- Quarterly Divestments fell 471.43% year-over-year to -$40000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$274000.0 (up 17.72% YoY) and the FY2022 annual result came in at -$157000.0, up 90.47% from the prior year.
- Divestments retreated to -$40000.0 in Q1 2023 per MESO's latest filing, from -$34000.0 in the prior quarter.
- Over five years, Divestments peaked at -$4000.0 in Q4 2021 and troughed at -$936000.0 in Q1 2021.
- A 5-year average of -$252588.2 and a median of -$99000.0 in 2021 frame the typical range for Divestments.
- The sharpest annual moves came in 2020 and 2022: Divestments sank 927.27% in 2020, then surged 99.25% in 2022.
- Over 5 years, Divestments stood at -$459000.0 in 2019, then gained by 11.33% to -$407000.0 in 2020, then surged by 99.02% to -$4000.0 in 2021, then sank by 750.0% to -$34000.0 in 2022, then retreated by 17.65% to -$40000.0 in 2023.
- According to Business Quant data, Divestments over the past three periods registered -$40000.0, -$34000.0, and -$153000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -37,000.00 |
| Mar 31, 2023 | -40,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Jun 30, 2021 | -223,000.00 |
| Mar 31, 2021 | -936,000.00 |
| Dec 31, 2020 | -407,000.00 |
| Sep 30, 2020 | -81,000.00 |
| Mar 31, 2020 | -1.31 Mn |
| Dec 31, 2019 | -612,000.00 |
| Sep 30, 2019 | -153,000.00 |
| Mar 31, 2019 | -90,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Sep 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Mar 31, 2018 | -37,000.00 |
| Dec 31, 2017 | -54,000.00 |
| Sep 30, 2017 | -83,000.00 |